Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study

Overview of attention for article published in Frontiers in Pharmacology, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy: 1 policy source

twitter: 7 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 43 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 59,837 followers.

Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study https://t.co/RiskBFBIuN

05 Jul 2022

Reply Repost Favourite

New Research: Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study https://t.co/rXkWMNCnIe #pharmacology

16 Jun 2022

Reply Repost Favourite

RT @HealthyFellow: #Ashwagandha as add-on therapy for #COPD patients: A randomized, placebo-controlled, double-blind study Attn: ⁦@_atanas_…

10 May 2022

Reply Repost Favourite

RT @HealthyFellow: #Ashwagandha as add-on therapy for #COPD patients: A randomized, placebo-controlled, double-blind study Attn: ⁦@_atanas_…

10 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.